MDxHealth, Plus Diagnostics to Co-promote Epigenetic Prostate Cancer Test
April 26, 2012
MDxHealth, Plus Diagnostics to Co-promote Epigenetic Prostate Cancer Test
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- MDxHealth Amends Biomarker Pact with Veridex
December 15, 2010 / GenomeWeb Daily News - GenomeDx, Mayo Clinic Expand Research Deal
April 29, 2013 / GenomeWeb Daily News - Prostate Cancer Risk Markers Show Promise for Test to ID Elevated Risk in Men with Benign Hyperplasia
April 3, 2013 / Pharmacogenomics Reporter - MDxHealth's Irvine Laboratory Receives ISO 9001:2008 Certification
April 2, 2013 / GenomeWeb Daily News - Oxford Gene Technology Licenses ICR Prostate Cancer Biomarker Panel
March 13, 2013 / GenomeWeb Daily News